CTOs on the Move

Verve Therapeutics

www.vervetx.com

 
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide. Headquartered in Cambridge, Mass., with a research facility in Philadelphia.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Emily Donlon
 Senior Director, Information Technology Profile
Andrew Sheely
 Vice President Information Technology Profile

Funding

Verve Therapeutics raised $58.5M on 05/07/2019
Verve Therapeutics raised $63M on 06/11/2020
Verve Therapeutics raised $94M on 01/19/2021

Similar Companies

Atmofizer

The world’s most innovative and effective clean air technology against harmful ultra fine particles incl. COVID-19. Developed in Germany, assembled in the US.

NotCo

Same taste, but plant-based. A food revolution has started. Know the future of food. Why not?

Ambulatory Services of America Inc

Ambulatory Services of America Inc is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SalioGen Therapeutics

SalioGen Therapeutics is advancing the Exact DNA Integration Technology (EDIT) platform, the only genome engineering technology that is mammal-derived, for use in potentially curative non-viral gene therapy.

Ganix

Ganix is a Las Vegas, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.